Jenn‐Yu Wu

Effectiveness of Tyrosine Kinase Inhibitors on “Uncommon” Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non–Small Cell Lung Cancer

Jenn‐Yu Wu, Chong‐Jen Yu, Yeun‐Chung Chang et al. · Clinical Cancer Research · 2011 · 466 citations · Full text

Medicine, Oncology, Pharmacology +14

Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response

Jenn‐Yu Wu, Shang‐Gin Wu, Chien‐Hung Gow et al. · Clinical Cancer Research · 2008 · 322 citations · Full text

Medicine, Oncology, Pharmacology +13

The Role of Non-invasive Ventilation and Factors Predicting Extubation Outcome in Myasthenic Crisis

Jenn‐Yu Wu, Ping‐Hung Kuo, Pi‐Chuan Fan et al. · Neurocritical Care · 2008 · 79 citations

Medicine, Anesthesiology, Surgery +15

Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (<i>EGFR</i>) Mutations with the Classical Mutation Pattern

Shang‐Gin Wu, Yih‐Leong Chang, Y. L. Hsu et al. · The Oncologist · 2008 · 77 citations

Medicine, Oncology, Pharmacology +14

Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations

Jenn‐Yu Wu, Shang‐Gin Wu, Yih‐Leong Chang et al. · Lung Cancer · 2010 · 75 citations

Medicine, Oncology, Pharmacology +9